{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T22:25:49Z","timestamp":1794435949929,"version":"4.9.1"},"reference-count":65,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006004","name":"Tohoku University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006004","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004948","name":"Astellas Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004948","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.omtn.2026.102925","type":"journal-article","created":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T02:07:04Z","timestamp":1775182024000},"page":"102925","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["From N-of-1 to versatility in propionic acidemia: Antisense oligonucleotide-mediated skipping of a constitutive PCCA pseudoexon"],"prefix":"10.1016","volume":"37","author":[{"given":"Eriko","family":"Totsune","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2188-5608","authenticated-orcid":false,"given":"Yoichi","family":"Wada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuko","family":"Mikami-Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsuko","family":"Arai-Ichinoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Saijo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Takayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Ohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeo","family":"Kure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuo","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2026.102925_bib1","series-title":"GeneReviews\u00ae [Internet]","article-title":"Propionic Acidemia","author":"Aima","year":"2012"},{"key":"10.1016\/j.omtn.2026.102925_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108501","article-title":"Pathophysiological mechanisms of complications associated with propionic acidemia","volume":"249","author":"Marchuk","year":"2023","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.omtn.2026.102925_bib3","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ymgme.2011.09.026","article-title":"Acute management of propionic acidemia","volume":"105","author":"Chapman","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.omtn.2026.102925_bib4","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s13023-022-02271-3","article-title":"Analysis of the relationship between phenotypes and genotypes in 60 Chinese patients with propionic acidemia: a fourteen-year experience at a tertiary hospital","volume":"17","author":"Liu","year":"2022","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.omtn.2026.102925_bib5","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ymgme.2018.09.008","article-title":"Identification of 34 novel mutations in propionic acidemia: Functional characterization of missense variants and phenotype associations","volume":"125","author":"Rivera-Barahona","year":"2018","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.omtn.2026.102925_bib6","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/sj.ejhg.5200442","article-title":"Potential relationship between genotype and clinical outcome in propionic acidaemia patients","volume":"8","author":"P\u00e9rez-Cerd\u00e1","year":"2000","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.omtn.2026.102925_bib7","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ymgme.2004.08.001","article-title":"Propionic acidemia: mutation update and functional and structural effects of the variant alleles","volume":"83","author":"Desviat","year":"2004","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.omtn.2026.102925_bib8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0925-4439(03)00039-5","article-title":"Functional analysis of PCCB mutations causing propionic acidemia based on expression studies in deficient human skin fibroblasts","volume":"1638","author":"P\u00e9rez-Cerd\u00e1","year":"2003","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.omtn.2026.102925_bib9","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00439-002-0761-z","article-title":"Unexpectedly high prevalence of the mild form of propionic acidemia in Japan: presence of a common mutation and possible clinical implications","volume":"111","author":"Yorifuji","year":"2002","journal-title":"Hum. Genet."},{"key":"10.1016\/j.omtn.2026.102925_bib10","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jchromb.2017.02.003","article-title":"Determination of methylmalonyl coenzyme A by ultra high-performance liquid chromatography tandem mass spectrometry for measuring propionyl coenzyme A carboxylase activity in patients with propionic acidemia","volume":"1046","author":"Gotoh","year":"2017","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.omtn.2026.102925_bib11","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/jimd.12370","article-title":"Guidelines for the diagnosis and management of methylmalonic acidaemia and propionic acidaemia: First revision","volume":"44","author":"Forny","year":"2021","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.omtn.2026.102925_bib12","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/1750-1172-8-148","article-title":"Long-term neurological outcome of a cohort of 80 patients with classical organic acidurias","volume":"8","author":"Nizon","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.omtn.2026.102925_bib13","article-title":"Natural history of propionic acidemia in the Amish population","volume":"33","author":"Ehrenberg","year":"2022","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.omtn.2026.102925_bib14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10545-011-9419-0","article-title":"Propionic acidemia: neonatal versus selective metabolic screening","volume":"35","author":"Gr\u00fcnert","year":"2012","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.omtn.2026.102925_bib15","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1186\/s13023-024-03468-4","article-title":"Role of carglumic acid in the long-term management of propionic and methylmalonic acidurias","volume":"19","author":"Yap","year":"2024","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.omtn.2026.102925_bib16","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1002\/lt.25344","article-title":"The Role of Liver Transplantation in Propionic Acidemia","volume":"24","author":"Quintero","year":"2018","journal-title":"Liver Transpl."},{"key":"10.1016\/j.omtn.2026.102925_bib17","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jpeds.2009.07.002","article-title":"Cardiomyopathies in Propionic Aciduria are Reversible After Liver Transplantation","volume":"156","author":"Romano","year":"2010","journal-title":"J. Pediatr."},{"key":"10.1016\/j.omtn.2026.102925_bib18","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1399-3046.2011.01607.x","article-title":"Living-donor liver transplantation for propionic acidemia","volume":"16","author":"Kasahara","year":"2012","journal-title":"Pediatr. Transplant."},{"key":"10.1016\/j.omtn.2026.102925_bib19","doi-asserted-by":"crossref","DOI":"10.1111\/petr.14886","article-title":"The Impact of Early Indication of Living Donor Liver Transplantation on the Outcomes of Patients With Propionic Acidemia: A Single-Center Experience","volume":"28","author":"Nakao","year":"2024","journal-title":"Pediatr. Transplant."},{"key":"10.1016\/j.omtn.2026.102925_bib20","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1097\/TP.0000000000003501","article-title":"Liver Transplantation for Propionic Acidemia: Evidence From a Systematic Review and Meta-analysis","volume":"105","author":"Zhou","year":"2021","journal-title":"Transplantation"},{"key":"10.1016\/j.omtn.2026.102925_bib21","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/lt.22279","article-title":"Liver transplantation for propionic acidemia in children","volume":"17","author":"Vara","year":"2011","journal-title":"Liver Transpl."},{"key":"10.1016\/j.omtn.2026.102925_bib22","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1111\/ajt.16400","article-title":"Fatal metabolic stroke in a child with propionic acidemia 11 years post liver transplant","volume":"21","author":"Sivananthan","year":"2021","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.omtn.2026.102925_bib23","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/ajt.13027","article-title":"Early and Late Complications After Liver Transplantation for Propionic Acidemia in Children: A Two Centers Study","volume":"15","author":"Charbit-Henrion","year":"2015","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.omtn.2026.102925_bib24","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/s41576-022-00541-1","article-title":"Prime editing for precise and highly versatile genome manipulation","volume":"24","author":"Chen","year":"2023","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.omtn.2026.102925_bib25","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s12033-022-00567-0","article-title":"A Review on the Mechanism and Applications of CRISPR\/Cas9\/Cas12\/Cas13\/Cas14 Proteins Utilized for Genome Engineering","volume":"65","author":"Hillary","year":"2023","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.omtn.2026.102925_bib26","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1089\/hum.2024.230","article-title":"Adeno-Associated Virus Gene Therapy Development: Early Planning and Regulatory Considerations to Advance the Platform Vector Gene Therapy Program","volume":"36","author":"Lomash","year":"2025","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtn.2026.102925_bib27","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1089\/nat.2022.0036","article-title":"Translational Pharmacokinetic\/Pharmacodynamic Model for mRNA-3927, an Investigational Therapeutic for the Treatment of Propionic Acidemia","volume":"33","author":"Attarwala","year":"2023","journal-title":"Nucleic Acid Ther."},{"key":"10.1016\/j.omtn.2026.102925_bib28","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/jimd.12665","article-title":"Gene therapy for organic acidemias: Lessons learned from methylmalonic and propionic acidemia","volume":"47","author":"Chandler","year":"2024","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.omtn.2026.102925_bib29","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1089\/hum.2010.164","article-title":"Adeno-Associated Virus Serotype 8 Gene Transfer Rescues a Neonatal Lethal Murine Model of Propionic Acidemia","volume":"22","author":"Chandler","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtn.2026.102925_bib30","doi-asserted-by":"crossref","first-page":"3494","DOI":"10.1093\/nar\/gkl498","article-title":"Defective splicing, disease and therapy: searching for master checkpoints in exon definition","volume":"34","author":"Buratti","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2026.102925_bib31","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s10038-005-0272-6","article-title":"A novel cryptic exon identified in the 3\u2032 region of intron 2 of the human dystrophin gene","volume":"50","author":"Tran","year":"2005","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.omtn.2026.102925_bib32","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1089\/nat.2022.0060","article-title":"Consensus Guidelines for the Design and In Vitro Preclinical Efficacy Testing N-of-1 Exon Skipping Antisense Oligonucleotides","volume":"33","author":"Aartsma-Rus","year":"2023","journal-title":"Nucleic Acid Ther."},{"key":"10.1016\/j.omtn.2026.102925_bib33","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1038\/s41467-020-17093-9","article-title":"Antisense oligonucleotide modulation of non-productive alternative splicing upregulates gene expression","volume":"11","author":"Lim","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2026.102925_bib34","first-page":"179","article-title":"Antisense oligonucleotide therapies for monogenic disorders","volume":"37","author":"Krey-Grauert","year":"2025","journal-title":"Med. Genet."},{"key":"10.1016\/j.omtn.2026.102925_bib35","doi-asserted-by":"crossref","first-page":"999","DOI":"10.3390\/genes15080999","article-title":"Recent Progress in Gene-Targeting Therapies for Spinal Muscular Atrophy: Promises and Challenges","volume":"15","author":"Haque","year":"2024","journal-title":"Genes"},{"key":"10.1016\/j.omtn.2026.102925_bib36","doi-asserted-by":"crossref","first-page":"777","DOI":"10.3390\/genes16070777","article-title":"Brogidirsen and Exon 44 Skipping for Duchenne Muscular Dystrophy: Advances and Challenges in RNA-Based Therapy","volume":"16","author":"Tang","year":"2025","journal-title":"Genes"},{"key":"10.1016\/j.omtn.2026.102925_bib37","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s41573-021-00162-z","article-title":"Antisense technology: an overview and prospectus","volume":"20","author":"Crooke","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omtn.2026.102925_bib38","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1086\/522376","article-title":"Propionic and Methylmalonic Acidemia: Antisense Therapeutics for Intronic Variations Causing Aberrantly Spliced Messenger RNA","volume":"81","author":"Rinc\u00f3n","year":"2007","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.omtn.2026.102925_bib39","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/s41586-023-06277-0","article-title":"A framework for individualized splice-switching oligonucleotide therapy","volume":"619","author":"Kim","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2026.102925_bib40","doi-asserted-by":"crossref","first-page":"4627","DOI":"10.1093\/nar\/gkv275","article-title":"Splice-shifting oligonucleotide (SSO) mediated blocking of an exonic splicing enhancer (ESE) created by the prevalent c.903+469T>C MTRR mutation corrects splicing and restores enzyme activity in patient cells","volume":"43","author":"Palhais","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2026.102925_bib41","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1056\/NEJMoa1813279","article-title":"Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease","volume":"381","author":"Kim","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omtn.2026.102925_bib42","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/hmg\/8.1.107","article-title":"Detection of a Normally Rare Transcript in Propionic Acidemia Patients with mRNA Destabilizing Mutations in the PCCA Gene","volume":"8","author":"Campeau","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtn.2026.102925_bib43","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1023\/A:1005506819699","article-title":"An 84bp insertion found in a propionic acidaemia patient is not a disease-causing mutation but a product of cryptic mRNA","volume":"22","author":"Ohura","year":"1999","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.omtn.2026.102925_bib44","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1146\/annurev-genet-112414-054639","article-title":"Nonsense-Mediated mRNA Decay: Degradation of Defective Transcripts Is Only Part of the Story","volume":"49","author":"He","year":"2015","journal-title":"Annu. Rev. Genet."},{"key":"10.1016\/j.omtn.2026.102925_bib45","article-title":"Identification of translation events that drive nonsense-mediated mRNA decay reveals functional roles for noncoding RNAs","author":"Young","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.omtn.2026.102925_bib46","first-page":"33","article-title":"Unequal synthesis and differential degradation of propionyl CoA carboxylase subunits in cells from normal and propionic acidemia patients","volume":"45","author":"Ohura","year":"1989","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.omtn.2026.102925_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2023.102101","article-title":"Regulating PCCA gene expression by modulation of pseudoexon splicing patterns to rescue enzyme activity in propionic acidemia","volume":"35","author":"Spangsberg Petersen","year":"2024","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2026.102925_bib48","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.cell.2018.12.015","article-title":"Predicting Splicing from Primary Sequence with Deep Learning","volume":"176","author":"Jaganathan","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2026.102925_bib49","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"10.1016\/j.omtn.2026.102925_bib50","doi-asserted-by":"crossref","first-page":"W193","DOI":"10.1093\/nar\/gkab442","article-title":"eSkip-Finder: a machine learning-based web application and database to identify the optimal sequences of antisense oligonucleotides for exon skipping","volume":"49","author":"Chiba","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2026.102925_bib51","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/BF01247343","article-title":"The molecular defect in propionic acidemia: Exon skipping caused by an 8-bp deletion from an intron in the PCCB allele","volume":"92","author":"Ohura","year":"1993","journal-title":"Hum. Genet."},{"key":"10.1016\/j.omtn.2026.102925_bib52","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ymgme.2004.01.003","article-title":"Mutation spectrum of the PCCA and PCCB genes in Japanese patients with propionic acidemia","volume":"81","author":"Yang","year":"2004","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.omtn.2026.102925_bib53","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/BF01213089","article-title":"Genetic heterogeneity of propionic acidemia: Analysis of 15 Japanese patients","volume":"87","author":"Ohura","year":"1991","journal-title":"Hum. Genet."},{"key":"10.1016\/j.omtn.2026.102925_bib54","doi-asserted-by":"crossref","first-page":"6518","DOI":"10.1093\/nar\/gkw236","article-title":"The delivery of therapeutic oligonucleotides","volume":"44","author":"Juliano","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2026.102925_bib55","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.omtn.2016.12.003","article-title":"Preclinical and Clinical Advances of GalNAc-Decorated Nucleic Acid Therapeutics","volume":"6","author":"Huang","year":"2017","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2026.102925_bib56","doi-asserted-by":"crossref","first-page":"8796","DOI":"10.1093\/nar\/gku531","article-title":"Targeted delivery of antisense oligonucleotides to hepatocytes using triantennary N-acetyl galactosamine improves potency 10-fold in mice","volume":"42","author":"Prakash","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2026.102925_bib57","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/nature09302","article-title":"Crystal structure of the \u03b16\u03b26 holoenzyme of propionyl-coenzyme A carboxylase","volume":"466","author":"Huang","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2026.102925_bib58","article-title":"Successful heart transplantation in a patient with adolescent-onset dilated cardiomyopathy secondary to propionic acidaemia: a case report","volume":"6","author":"Seguchi","year":"2022","journal-title":"Eur. Heart J. Case Rep."},{"key":"10.1016\/j.omtn.2026.102925_bib59","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/mt.2013.68","article-title":"Generation of a Hypomorphic Model of Propionic Acidemia Amenable to Gene Therapy Testing","volume":"21","author":"Guenzel","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2026.102925_bib60","doi-asserted-by":"crossref","first-page":"35995","DOI":"10.1074\/jbc.M105467200","article-title":"Fatal Propionic Acidemia in Mice Lacking Propionyl-CoA Carboxylase and Its Rescue by Postnatal, Liver-specific Supplementation via a Transgene","volume":"276","author":"Miyazaki","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omtn.2026.102925_bib61","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1089\/hum.2008.158","article-title":"Short-Term Rescue of Neonatal Lethality in a Mouse Model of Propionic Acidemia by Gene Therapy","volume":"20","author":"Hofherr","year":"2009","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtn.2026.102925_bib62","first-page":"656","article-title":"BLAT\u2014The BLAST-Like Alignment Tool","volume":"12","author":"Kent","year":"2002","journal-title":"Genome Res."},{"key":"10.1016\/j.omtn.2026.102925_bib63","doi-asserted-by":"crossref","first-page":"D756","DOI":"10.1093\/nar\/gkt1114","article-title":"RefSeq: an update on mammalian reference sequences","volume":"42","author":"Pruitt","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2026.102925_bib64","doi-asserted-by":"crossref","first-page":"D501","DOI":"10.1093\/nar\/gki025","article-title":"NCBI Reference Sequence (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteins","volume":"33","author":"Pruitt","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2026.102925_bib65","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/s41467-020-20146-8","article-title":"Construction and integration of three de novo Japanese human genome assemblies toward a population-specific reference","volume":"12","author":"Takayama","year":"2021","journal-title":"Nat. Commun."}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S216225312600096X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S216225312600096X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T21:33:25Z","timestamp":1794432805000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S216225312600096X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":65,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S216225312600096X"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2026.102925","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From N-of-1 to versatility in propionic acidemia: Antisense oligonucleotide-mediated skipping of a constitutive PCCA pseudoexon","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2026.102925","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"102925"}}